Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 May 10.
Published in final edited form as: J Cancer Educ. 2011 Sep;26(3):586–590. doi: 10.1007/s13187-011-0250-y

Transdisciplinary training in cancer prevention: Reflections on two decades of training

Graham A Colditz 1, Kathleen Y Wolin 1
PMCID: PMC3650471  NIHMSID: NIHMS453261  PMID: 21698522

With release of an RFA in 1991 to promote cancer prevention and control training (Education Programs in Cancer Prevention and Control (RFA CA-91-20)), one of us (GAC) worked with colleagues (Drs. Frederick P. Li, Diana Chapman Walsh, and Walter C. Willett, at Harvard School of Public Health) to frame an innovative, new training program in cancer prevention. While Harvard School of Public Health had a long history of training classic cancer epidemiologists focused on pathobiology through an established T32 training program (T32-00001) and a training program in environmental epidemiology (T32 ES 07069), little attention had been paid to issues in the use of epidemiologic data to inform prevention strategies that might reduce the burden of cancer on society1,2.

Specifically, the RFA sought programs that combined multidisciplinary curricula with ongoing cancer prevention research so that trainees would “gain experiences ranging from research on innovative hypothesis testing and the impact of interventions on defined populations to the broad, systematic application of the research results.” We framed a training program and built support within the School and affiliated teaching hospitals (Brigham and Women’s Hospital and Dana Farber Cancer Institute) to place greater emphasis on cancer prevention and control training opportunities. In 1994, Dean of the School of Public Health, Harvey Fineberg, established the Center for Cancer Prevention as a school-wide priority, interdepartmental, and interdisciplinary in nature. The goals of the Center were: to promote research to speed development of cancer prevention strategies; to foster education programs for future leaders in cancer prevention; to communicate to the public what we know about cancer prevention; and to translate scientific findings into applied public health messages. With this institutional commitment and NCI funding, we built a program that would train future leaders in cancer prevention sciences. The training program became known as the Harvard Cancer Prevention Education Program.

The Center for Cancer Prevention was an underlying institutional structure and resource to support training and offer additional scholarship, particularly for those from foreign countries not eligible for NIH training support. Dr. Dimitrios Trichopoulos served as the Director and Dr. Graham Colditz as Education Director. Among the major goals of the Center were to foster interdisciplinary education in cancer prevention. At the same time, the Department of Health and Social Behavior (Dr. Diana C. Walsh, Chair, HSPH) and the Division of Cancer Epidemiology and Control (F.P. Li, Chair, DFCI) jointly established a research program in community based cancer prevention led by Drs. Glorian Sorensen and Karen Emmons.

The goal of the Harvard Cancer Prevention Education Program was to create a cadre of public health and clinical professionals who would be:

  1. knowledgeable about the current state of the science of cancer prevention;

  2. experts in a specialized research area in which they will be positioned to generate new knowledge and public health practice to advance cancer prevention;

  3. skilled in policy analysis; and

  4. sufficiently well anchored in professional networks that they will be able to monitor future developments in the field of cancer prevention and translate their knowledge into cancer control programs at a variety of institutional levels.

We established a multidisciplinary team of leaders to guide the training program. Leadership included faculty whose research spanned aspects of cancer prevention and who had disciplinary training in behavioral sciences, epidemiology, and health policy. Initially, trainees undertook coursework in disciplines underpinning cancer prevention and control, gaining familiarity with the vocabulary and concepts of the disciplines, and concurrently pursued related research in epidemiology, health behavior change, and communication sciences. Over time, we expanded the range of disciplines that we included in the training program, for example adding decision sciences in 2000. We built a mentoring program to foster the principles of cancer prevention, and required joint mentoring from a primary discipline and an additional related or “outside” discipline. We encouraged applied research projects from the beginning, as we saw the need to speed translation of research to practice to achieve the potential for cancer prevention 3.

As a first step in implementing the vision for training in cancer prevention, we expanded the curriculum within the HSPH to include Screening (Drs. Colditz and Ichiro Kawachi); refocused a course on meta-analysis and research synthesis (Drs. Colditz, F. Mosteller, N. Laird), and built a core course in cancer prevention (Drs. Colditz and Walsh) that would expose trainees to the broad range of perspectives and scientific disciplines that bear on and underpin effective prevention initiatives. This course was required for all trainees and gave a grounding on which they might build research and training opportunities that fostered transdisciplinary research.

Principles of Cancer Prevention course

The original training program proposal submitted to peer review promised a new course in cancer prevention, distinct from the existing cancer epidemiology course. Two faculty members (Drs. Colditz and Walsh) took responsibility for developing this new course after review of existing courses from other cancer centers and public health programs across the country. This review showed no existing courses were covering the breadth of disciplines we saw as fundamental to the future of cancer prevention, moving from biology of cancer to epidemiology, behavior, survivorship and prevention through health care providers, social and behavioral strategies, and regulatory approaches

Combining both a societal perspective as emphasized by Rose 4 and the biologic underpinnings of disease etiology and prevention (epidemiology, incidence, mortality, decision science, risk communication, behavior change, health policy), our instruction ranged from the basic biology of cancer to the social impact of cancer as recounted through the eyes of a childhood cancer survivor. In essence, we aimed to bring students to an understanding of the interplay of cancer biology, etiology, prevention, policy, and strategies to sustain healthier lives free from cancer. By completing the course, students were expected to be proficient in the language of these divergent scientific disciplines and understand how through a social ecologic approach 5 one can to bring these disciplinary perspectives together to inform prevention priorities.

Considering strategies for prevention, we addressed the leading causes of cancer (tobacco, lack of exercise, diet, obesity, occupation, and sun exposure)3. Over time, this set of exposures evolved to consider broader environmental causes of cancer as well as the role of viruses and the range of strategies available to reduce risk within society from interventions through health care providers, through regulation, and through interventions at the individual and community level. Cancer prevention and control methodology for interventions and evaluation of programs rounded out the curriculum. See Table 1 for typical syllabus and readings (updated listing of references are available from the authors).

Table 1.

Topics for cancer prevention training, required course

Theme Topics Key reference
Introduction – overview Causes of cancer
Potential for prevention
National goals for cancer prevention
Richmond Model
Colditz et al. 23
Colditz et al.24
Byers et al. 25

Atwood et al. 7
Population perspective vs.
individual risk
Rose model
Risk perception and
communication
Rose 4
Cancer biology
Patient perspectives
Etiology - biology
Life course implications
Weinberg 26
Colditz 27
Causes Tobacco – cause of cancer
Tobacco - strategies for
control
Surgeon General reports
Surgeon General Reports
Obesity Calle et al 28
Inactivity / Physical activity
School based interventions to
promote activity (design for
dissemination)
Colditz et al. 29 IARC report30
Gortmaker et al 31
Viruses and vaccines Colditz 23
Environmental and
occupational exposures
More recent e.g., Boffetta 32
Diet and alcohol
Lessons from prevention trials
Key 33 Thun 34 Hunter 35
Schatzkin et al 36 Baron et al
37
Chemoprevention Principles, risk and benefits
Challenge of prevention trials
ATBC 38 Beta-carotene 39
Zelen 40
Screening Methodologic issues
Cervix example for methods
Colorectal screening example
Colditz 41
IARC work group42
Frazier 13
Policy strategies for
prevention
Colditz, Emmons 1, 43-44
Media approaches for
prevention
Working with media DeJong 45
Viswanath 46
Community based
participatory research and
prevention
Sorensen 47
Contribution of trials and
observational epidemiology to
informing prevention
Aspirin, Folate, and other
examples
WHI 48,49,
Aspirin 50-51
Dissemination and
sustainability
Models for dissemination
Strategies for evaluation
Glasgow 52 Colditz 53

A fundamental issue in developing the course was the identification of a unifying approach to place the biology, evidence on population burden, strategies for prevention, and priority in society, in a coherent framework 2. The Richmond model 6-7 became the central structure for the course, given that this model had not only been used by the US Department of Health and Human Services to frame Healthy People agenda (http://www.cdc.gov/nchs/healthy_people.htm), but it also offered the students a structure to insure they consider the scope of the challenge of moving cancer prevention forward. To make this applicable to the interests of the class participants we required a class team assignment – this emphasized collaboration across disciplines and required development of a strategy for cancer prevention or control.

Beyond the coursework, doctoral students in cancer prevention were encouraged to obtain experience outside their home discipline, either through collaboration on cancer prevention projects 8 or through participation in Harvard Center for Cancer Prevention / Dana Farber-Harvard Cancer Center activities that were structured to bring investigators together across disciplines 9-11. At the post-doctoral level, medical oncologists gained training in epidemiology and behavioral sciences 12-14 as complements to their clinical skills. The training program required department chairs to buy-in to broader themes for dissertation research than the more traditional tight disciplinary focus at Harvard School of Public Health. For example, a thesis in the epidemiology department may include traditional cohort study prospective data analysis with repeated measures, and an evaluation of a behavioral intervention, and a paper addressing methods issues in prevention. In addition to these activities, the trainees attended a monthly session specifically for them to review progress on their research. When leaders in the field visited the Harvard School of Public Health to participate in the Cancer Prevention seminar series, trainees had the opportunity to share lunch with the visiting faculty and discuss career challenges, opportunities, and begin building professional networks.

Preparation for Transdisciplinary Training

Emphasis on transdisciplinary training has grown over the past 20 years with substantial leadership from NCI through funding of TTURC and of other Transdisciplinary centers (http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-98-029.html)15. Our program predated this emphasis. Priorities in training for a transdisciplinary research career extend beyond a single course and must be reflected in broader demands for doctoral level trainees that range from thesis committee membership, structure of mentoring, and expectations for thesis projects. At the post-doctoral level, this requires an individualized training program with specific career development objectives that build on prior training and bridge across disciplines through participation in seminars and ongoing research projects. Effective Transdisciplinary Centers in Health Disparities, for example, show 1) evidence of collaboration across schools, health care institutions, and community organizations; 2) capacity building through seminars etc; 3) development of new common conceptual language; 4) emergence of new lines of inquiry; and 5) innovation in development of new instruments and analytic methods 16.

A central theme in the teaching and mentoring of trainees was an emphasis on applying knowledge to speed the translation of research to effective prevention programs.17 Consistent wit the goals of the program, trainees have subsequently pursued careers in a range of settings including at the NCI in the Division of Cancer Control and Population Sciences (e.g., Fagan 18-19); in academic research settings (e.g., Fuchs 12, 20; Linnan21 ); and at CDC (Sabatino 22).

A more formal evaluation of this or other training programs would assess the long-term outcome of trainees in terms of their contribution to cancer prevention. This may be through service in any of the areas met by the goals of the training program. One might ask what the time frame for such an evaluation should be? Is 10 years after completing training insufficient to assess the benefits of the program? For example Fuchs, noted above, was a trainee in 1994-95. Other more recent trainees hold faculty posts in public health and as researchers in public health agencies (see table 2). In sum, evaluation may be more complex than for a traditional T32 where the primary research careers of trainees can be evaluated through national databases of grants and publications.

Table 2.

Prior trainees in cancer prevention, focus of training, institution and current position

Trainee Topic Institution Position
Abroms, L Tobacco control George Washington
University
Assistant Professor
Allen, JD Screening and access Dana-Farber / Harvard
Medical School
Assistant Professor
Ahn, R Social epidemiology Massachusetts
general Hospital
Manager, Center for
Global Health
Barclay, G Prevention –
communication
strategies
Aetna Foundation V-P Programs
Bates, L Social epidemiology Columbia University Assistant Professor
Case, P Contraception U Vermont Assistant Res.
Professor
De Moor, J S Communication Ohio State College of
Public Health
Assistant Professor
Fagan, P Tobacco control NCI , Tobacco Control
Research Branch
Program Director,
Health Scientist
LaMontagne, A Occupational health U Melbourne,
Australia
Associate Professor
Perry, M Occupational health Harvard School of
Public Health
Associate Professor
Syngal, S Colon cancer
screening
Harvard Medical
School
Associate Professor
Wolin, K Colon Cancer
Prevention /physical
activity
Washington
University in St Louis
Assistant Professor

Accessed 4-April 24, 2011 and updated web pages of trainees

An integrated program that challenges trainees to apply knowledge to speed translation from research to effective prevention strategies and programs has led to a range of prevention scientists pursing careers in cancer prevention. This funding mechanism from NCI appears to have been successful in speeding development of the discipline and training a new generation of academic and public health leaders. A diverse leadership team may be one of the key elements of modeling such an interdisciplinary program.

Literature cited

  • 1.Colditz GA. Epidemiology as the basis for clinical and social policy decisions. Int J Epidemiol. 1985 Jun;14(2):336–337. doi: 10.1093/ije/14.2.336. [DOI] [PubMed] [Google Scholar]
  • 2.Colditz G, Gortmaker S. Cancer prevention strategies for the future: risk identification and prevention intervention. Millbank Q. 1995;73:621–651. [PubMed] [Google Scholar]
  • 3.Willett W, Colditz G, Mueller N. Strategies for minimizing cancer risk. Scientific American. 1996;275(3):88–95. doi: 10.1038/scientificamerican0996-88. [DOI] [PubMed] [Google Scholar]
  • 4.Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J - Clin Res. 1981;282:1847–1851. doi: 10.1136/bmj.282.6279.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Stokols D. Establishing and maintaining healthy environments. Toward a social ecology of health promotion. The American psychologist. 1992 Jan;47(1):6–22. doi: 10.1037//0003-066x.47.1.6. [DOI] [PubMed] [Google Scholar]
  • 6.Richmond J, Kotelchuck M. Coordination and development of strategies and policy for public health promotion in the United States. In: Holland W, Detel R, Know G, editors. Oxford Textbook of Public Health. Vol 1. Oxford University Press; Oxford: 1991. [Google Scholar]
  • 7.Atwood K, Colditz GA, Kawachi I. From public health science to prevention policy: placing science in its social and political contexts. Am J Public Health. 1997 Oct;87(10):1603–1606. doi: 10.2105/ajph.87.10.1603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wolin KY, Colditz G, Stoddard AM, Emmons KM, Sorensen G. Acculturation and physical activity in a working class multiethnic population. Prev Med. 2006 Apr;42(4):266–272. doi: 10.1016/j.ypmed.2006.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Schernhammer ES. Harvard launches a workshop series targeting the control of obesity in the US. Cancer Causes Control. 2003 Dec;14(10):1009–1012. doi: 10.1023/b:caco.0000008004.64911.55. [DOI] [PubMed] [Google Scholar]
  • 10.Cradock AL. Tobacco control among adolescents: report from a workshop at the Harvard Center for Cancer Prevention. Cancer Causes Control. 2000 Oct;11(9):875–876. doi: 10.1023/a:1008903503457. [DOI] [PubMed] [Google Scholar]
  • 11.Cradock AL. Research questions concerning hepatitis C virus: report from a workshop at the Harvard Center for Cancer Prevention. Cancer Causes Control. 1999 Dec;10(6):485–487. doi: 10.1023/a:1008914103840. [DOI] [PubMed] [Google Scholar]
  • 12.Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994 Dec 22;331(25):1669–1674. doi: 10.1056/NEJM199412223312501. [DOI] [PubMed] [Google Scholar]
  • 13.Frazier A, Colditz G, Fuchs C, Kuntz K. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954–1961. doi: 10.1001/jama.284.15.1954. [DOI] [PubMed] [Google Scholar]
  • 14.Geller AC, Colditz G, Oliveria S, et al. Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics. 2002;109(6):1009–1014. doi: 10.1542/peds.109.6.1009. [DOI] [PubMed] [Google Scholar]
  • 15.Warnecke RB, Oh A, Breen N, et al. Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health. 2008 Sep;98(9):1608–1615. doi: 10.2105/AJPH.2006.102525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Holmes JH, Lehman A, Hade E, et al. Challenges for multilevel health disparities research in a transdisciplinary environment. Am J Prev Med. 2008 Aug;35(2 Suppl):S182–192. doi: 10.1016/j.amepre.2008.05.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Colditz GA. From epidemiology to cancer prevention: implications for the 21st Century. Cancer Causes Control. 2007 Mar;18(2):117–123. doi: 10.1007/s10552-007-0117-z. [DOI] [PubMed] [Google Scholar]
  • 18.Fagan P, Stoddard AM, Hunt MK, Frazier L, Girod K, Sorensen G. The feasibility of evaluating a tobacco control intervention for working youth. Tob Control. 2003 Dec;12(Suppl 4):IV34–39. doi: 10.1136/tc.12.suppl_4.iv34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fagan P, King G, Lawrence D, et al. Eliminating tobacco-related health disparities: directions for future research. Am J Public Health. 2004 Feb;94(2):211–217. doi: 10.2105/ajph.94.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary Fiber and the Risk of Colorectal Cancer and Adenoma in Women. N Engl J Med. 1999 Jan 21;340(3):169–176. doi: 10.1056/NEJM199901213400301. 1999. [DOI] [PubMed] [Google Scholar]
  • 21.Linnan LA, Sorensen G, Colditz G, Klar DN, Emmons KM. Using theory to understand the multiple determinants of low participation in worksite health promotion programs. Health Educ Behav. 2001 Oct;28(5):591–607. doi: 10.1177/109019810102800506. [DOI] [PubMed] [Google Scholar]
  • 22.Sabatino SA, Burns RB, Davis RB, Phillips RS, Chen YH, McCarthy EP. Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey. Cancer. 2004 Jun 1;100(11):2338–2346. doi: 10.1002/cncr.20274. [DOI] [PubMed] [Google Scholar]
  • 23.Colditz GA, DeJong D, Hunter DJ, Trichopoulos D, Willett WC. Harvard Report on Cancer Prevention. Volume 1. Causes of Human Cancer. Cancer Causes Control. 1996;7(Suppl 1):1–59. [Google Scholar]
  • 24.Colditz GA, DeJong D, Emmons K, Hunter DJ, Mueller N, Sorensen G. Harvard Report on Cancer Prevention. Volume 2. Prevention of Human Cancer. Cancer Causes Control. 1997:8. [Google Scholar]
  • 25.Byers T, Mouchawar J, Marks J, et al. The American Cancer Society challenge goals. How far can cancer rates decline in the U.S. by the year 2015? Cancer. 1999;86:715–727. [PubMed] [Google Scholar]
  • 26.Weinberg RA. How cancer arises. Sci Am. 1996 Sep;275(3):62–70. doi: 10.1038/scientificamerican0996-62. [DOI] [PubMed] [Google Scholar]
  • 27.Colditz G, Frazier A. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev. 1995;4:567–571. [PubMed] [Google Scholar]
  • 28.Calle E, Thun M, Petrelli J, Rodriguez C, Health C. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–1105. doi: 10.1056/NEJM199910073411501. [DOI] [PubMed] [Google Scholar]
  • 29.Colditz G, Cannuscio C, Frazier A. Physical activity and colon cancer. Cancer Causes Control. 1997:8. doi: 10.1023/a:1018458700185. [DOI] [PubMed] [Google Scholar]
  • 30.International Agency for Research on Cancer . Weight Control and Physical Activity. Vol 6. International Agency for Research on Cancer; Lyon: 2002. [Google Scholar]
  • 31.Gortmaker SL, Peterson K, Wiecha J, et al. Reducing obesity via a school-based interdisciplinary intervention among youth: Planet Health. Arch Pediatr Adolesc Med. 1999 May;153(4):409–418. doi: 10.1001/archpedi.153.4.409. [DOI] [PubMed] [Google Scholar]
  • 32.Boffetta P, McLaughlin JK, la Vecchia C, Autier P, Boyle P. ‘Environment’ in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis. 2007 May;28(5):913–915. doi: 10.1093/carcin/bgm034. [DOI] [PubMed] [Google Scholar]
  • 33.Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004 Feb;7(1A):187–200. doi: 10.1079/phn2003588. [DOI] [PubMed] [Google Scholar]
  • 34.Thun M, Peto R, Lopez A, et al. Alcohol consumption and mortality among middle-aged and elderly US adults. New Engl J Med. 1997;337:1705–1714. doi: 10.1056/NEJM199712113372401. [DOI] [PubMed] [Google Scholar]
  • 35.Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fat intake and the risk of breast cancer: a pooled analysis. N Eng J Med. 1996;334:356–361. doi: 10.1056/NEJM199602083340603. [DOI] [PubMed] [Google Scholar]
  • 36.Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 2000;342:1149–1155. doi: 10.1056/NEJM200004203421601. [DOI] [PubMed] [Google Scholar]
  • 37.Baron J, Beach M, Mandel J, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340:101–107. doi: 10.1056/NEJM199901143400204. [DOI] [PubMed] [Google Scholar]
  • 38.ATBC Study Group Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA. 2003;290:476–485. doi: 10.1001/jama.290.4.476. [DOI] [PubMed] [Google Scholar]
  • 39.Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145–1149. doi: 10.1056/NEJM199605023341801. [DOI] [PubMed] [Google Scholar]
  • 40.Zelen M. Are primary cancer prevention trials feasible? J Natl Cancer Inst. 1988;80:1442–1444. doi: 10.1093/jnci/80.18.1442. [DOI] [PubMed] [Google Scholar]
  • 41.Colditz G, Hoaglin D, Berkey C. Cancer incidence and mortality: the priority of screening frequency and population coverage. Milbank Q. 1997;75:147–173. doi: 10.1111/1468-0009.00050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.IARC work group Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes. Br Med J (Clin Res Ed) 1986 Sep 13;293(6548):659–664. doi: 10.1136/bmj.293.6548.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Colditz GA, Samplin-Salgado M, Ryan CT, et al. Harvard report on cancer prevention, volume 5: fulfilling the potential for cancer prevention: policy approaches. Cancer Causes Control. 2002;13(3):199–212. doi: 10.1023/a:1015040702565. [DOI] [PubMed] [Google Scholar]
  • 44.Emmons K, Colditz G. Preventing excess sun exposure: it is time for a national policy. J Natl Cancer Inst. 1999;91:1269–1270. doi: 10.1093/jnci/91.15.1269. [DOI] [PubMed] [Google Scholar]
  • 45.DeJong W. Prevention of tobacco use. Cancer Causes Control. 1997 Nov;8(Suppl 1):S5–8. [PubMed] [Google Scholar]
  • 46.Viswanath K. Science and society: the communications revolution and cancer control. Nat Rev Cancer. 2005 Oct;5(10):828–835. doi: 10.1038/nrc1718. [DOI] [PubMed] [Google Scholar]
  • 47.Sorensen G, Emmons K, Hunt MK, et al. Model for incorporating social context in health behavior interventions: applications for cancer prevention for working-class, multiethnic populations. Prev Med. 2003 Oct;37(3):188–197. doi: 10.1016/s0091-7435(03)00111-7. [DOI] [PubMed] [Google Scholar]
  • 48.Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333. doi: 10.1001/jama.288.3.321. [DOI] [PubMed] [Google Scholar]
  • 49.Prentice RL, Langer R, Stefanick ML, et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women’s Health Initiative clinical trial. Am J Epidemiol. 2005 Sep 1;162(5):404–414. doi: 10.1093/aje/kwi223. [DOI] [PubMed] [Google Scholar]
  • 50.Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep 7;333(10):609–614. doi: 10.1056/NEJM199509073331001. [DOI] [PubMed] [Google Scholar]
  • 51.Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007 May 12;369(9573):1603–1613. doi: 10.1016/S0140-6736(07)60747-8. [DOI] [PubMed] [Google Scholar]
  • 52.Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322–1327. doi: 10.2105/ajph.89.9.1322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Colditz G. Disseminating research findings into public health practice. Cancer Causes Control. 2002;13(6):503–504. doi: 10.1023/a:1016384225177. [DOI] [PubMed] [Google Scholar]

RESOURCES